Meloxicam Bluefish (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective action provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity to a greater extent.

The dosage of Meloxicam Bluefish is determined by the prescribing clinician based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of meloxicam in pregnancy or while breastfeeding has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam is a COX‑2‑selective NSAID, offering comparable anti‑inflammatory and analgesic efficacy to non‑selective NSAIDs such as ibuprofen, but with a potentially lower risk of gastrointestinal irritation. However, cardiovascular and renal safety profiles must still be considered, especially in high‑risk patients.

Meloxicam Bluefish should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Meloxicam Bluefish is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce occasional stomach upset. The exact administration schedule is set by the prescriber.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe liver enzyme elevations, renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice any of these signs.

Meloxicam Bluefish should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, and in patients with significant renal or hepatic impairment unless specifically directed by a physician.